{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidavn45i4ht5vsp7gzsfu5sj4o2mrmom2sjjwc42unxlo7nnptjqi",
    "uri": "at://did:plc:73txmnzc4imhrv5q7azno3up/app.bsky.feed.post/3mjmzzbui5p42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiam5euf3gpctq2qcsyjjdt3plbql3e2pnuktshlmn6xtrimxqbpuq"
    },
    "mimeType": "image/jpeg",
    "size": 96315
  },
  "path": "/science/166440-russia-dengue-vaccine-clinical-trials-explained/",
  "publishedAt": "2026-04-16T17:13:00.000Z",
  "site": "https://english.pravda.ru",
  "tags": [
    "Science"
  ],
  "textContent": "Russia has developed a recombinant genetically engineered vaccine against dengue fever, and its clinical trials are now beginning, according to Veronika Skvortsova, head of the Federal Medical-Biological Agency (FMBA).\n\"A recombinant genetically engineered vaccine against dengue fever has been developed, and its clinical trials are beginning,” she stated at a meeting of the FMBA.\nThe agency head уточнила that the vaccine was created following a request from the President of the Republic of Nicaragua, Daniel Ortega.",
  "title": "Russia Develops Dengue Fever Vaccine as Clinical Trials Begin"
}